Evidence map›Paper›PMID 36698077›Full record

ArticleBMC genomics2023

peaksat: an R package for ChIP-seq peak saturation analysis.

Joseph R Boyd, Cong Gao, Kathleen Quinn, Andrew Fritz, Janet Stein, Gary Stein, Karen Glass, Seth Frietze

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Joseph R BoydDepartment of Biomedical and Health Sciences, University of Vermont, 106 Carrigan Drive, 302 Rowell, VT, 04505, Burlington, USA.
Cong GaoDepartment of Biomedical and Health Sciences, University of Vermont, 106 Carrigan Drive, 302 Rowell, VT, 04505, Burlington, USA.
Kathleen QuinnDepartment of Biomedical and Health Sciences, University of Vermont, 106 Carrigan Drive, 302 Rowell, VT, 04505, Burlington, USA.
Andrew FritzDepartment of Biochemistry, University of Vermont, Burlington, VT, USA.
Janet SteinDepartment of Biochemistry, University of Vermont, Burlington, VT, USA.
Gary SteinDepartment of Biochemistry, University of Vermont, Burlington, VT, USA.
Karen GlassDepartment of Biochemistry, University of Vermont, Burlington, VT, USA.
Seth FrietzeDepartment of Biomedical and Health Sciences, University of Vermont, 106 Carrigan Drive, 302 Rowell, VT, 04505, Burlington, USA. seth.frietze@med.uvm.edu.
University of Vermont · US

Funding

Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-income and Homeless Populations and Testing Targeted InterventionsU54GM115516 · NIGMS · MAINEHEALTH · PI Robert A Koza · 2017 to 2026
$51.6M
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast CancerP01CA240685 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI STEIN, JANET L · 2021 to 2025
$8.7M
Chromatin Organization Regulates OsteogenesisR01DE029311 · NIDCR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI LIAN, JANE B., STEIN, GARY S. · 2020 to 2024
$2.5M
Studies to understand how mutations in the IKZF1 gene can contribute to development of autoimmune diseaseR01AI127709 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRIETZE, SETH E, SCHJERVEN, HILDE · 2018 to 2022
$2.1M
Deciphering the molecular mechanisms of histone code recognition by ATAD2/BR01GM129338 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI FRIETZE, SETH E, GLASS, KAREN CHAMPAGNE · 2018 to 2022
$2.1M
Understanding Ikaros molecular functions for targeted therapies of pre-B ALLR01CA230618 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRIETZE, SETH E, SCHJERVEN, HILDE · 2018 to 2022
$1.8M
NCI NIH HHS P01 CA240685NCI NIH HHS R01 CA230618NIAID NIH HHS R01 AI127709NIDCR NIH HHS R01 DE029311NIGMS NIH HHS R01 GM129338NIGMS NIH HHS U54 GM115516NIH HHS R01AI127709NIH HHS R01GM129338NIH HHS U54GM115516
6 · The paper itself

Abstract

backgroundEpigenomic profiling assays such as ChIP-seq have been widely used to map the genome-wide enrichment profiles of chromatin-associated proteins and posttranslational histone modifications. Sequencing depth is a key parameter in experimental design and quality control. However, due to variable sequencing depth requirements across experimental conditions, it can be challenging to determine optimal sequencing depth, particularly for projects involving multiple targets or cell types.

resultsWe developed the peaksat R package to provide target read depth estimates for epigenomic experiments based on the analysis of peak saturation curves. We applied peaksat to establish the distinctive read depth requirements for ChIP-seq studies of histone modifications in different cell lines. Using peaksat, we were able to estimate the target read depth required per library to obtain high-quality peak calls for downstream analysis. In addition, peaksat was applied to other sequence-enrichment methods including CUT&RUN and ATAC-seq.

conclusionpeaksat addresses a need for researchers to make informed decisions about whether their sequencing data has been generated to an adequate depth and subsequently sufficient meaningful peaks, and failing that, how many more reads would be required per library. peaksat is applicable to other sequence-based methods that include calling peaks in their analysis.

Indexed as

Chromatin Immunoprecipitation SequencingHigh-Throughput Nucleotide SequencingGene LibrarySequence Analysis, DNAChIP-SeqPeak saturationRead depth estimate

Identifiers

PMID36698077
PMCPMC9878872
OpenAlexW4317937570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.